Clinical Trial Update: Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial in soft tissue sarcoma assessing doxorubicin plus ifosfamide with high-dose ICE; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Adriamycin (doxorubicin)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED